592 related articles for article (PubMed ID: 17609322)
1. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
[TBL] [Abstract][Full Text] [Related]
3. Study of fungal and bacterial infections of the diabetic foot.
Chincholikar DA; Pal RB
Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
[TBL] [Abstract][Full Text] [Related]
5. Bacteriological findings and antimicrobial resistance in odontogenic and non-odontogenic chronic maxillary sinusitis.
Puglisi S; Privitera S; Maiolino L; Serra A; Garotta M; Blandino G; Speciale A
J Med Microbiol; 2011 Sep; 60(Pt 9):1353-1359. PubMed ID: 21498651
[TBL] [Abstract][Full Text] [Related]
6. Isolation of bacteria from diabetic foot ulcers with special reference to anaerobe isolation by simple two-step combustion technique in candle jar.
Haldar J; Mukherjee P; Mukhopadhyay S; Maiti PK
Indian J Med Res; 2017 Jan; 145(1):97-101. PubMed ID: 28574021
[TBL] [Abstract][Full Text] [Related]
7. Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.
Goldstein EJ; Citron DM; Nesbit CA
Diabetes Care; 1996 Jun; 19(6):638-41. PubMed ID: 8725864
[TBL] [Abstract][Full Text] [Related]
8. Bacteriology of ophthalmic infections with special reference to anaerobes.
Aggarwal R; Chaudhry R; Mathur SP; Talwar V
Indian J Med Res; 1992 May; 95():148-51. PubMed ID: 1506066
[TBL] [Abstract][Full Text] [Related]
9. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
[TBL] [Abstract][Full Text] [Related]
11. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait.
Al Benwan K; Al Mulla A; Rotimi VO
J Infect Public Health; 2012 Mar; 5(1):1-8. PubMed ID: 22341838
[TBL] [Abstract][Full Text] [Related]
12. [Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabetic foot infection].
Shen Q; Lin D; Zhu H; Ge S; Wu W; Pan X; Gu X; Gu X; Shen F
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):889-94. PubMed ID: 24854906
[TBL] [Abstract][Full Text] [Related]
13. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Michalska W; Chylak J; Pietkiewicz K
Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
Pelak BA; Citron DM; Motyl M; Goldstein EJ; Woods GL; Teppler H
J Antimicrob Chemother; 2002 Nov; 50(5):735-41. PubMed ID: 12407133
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Goldstein EJ; Conrads G; Citron DM; Merriam CV; Warren Y; Tyrrell K
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):113-8. PubMed ID: 11858906
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
[TBL] [Abstract][Full Text] [Related]
20. Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
Tascini C; Piaggesi A; Tagliaferri E; Iacopi E; Fondelli S; Tedeschi A; Rizzo L; Leonildi A; Menichetti F
Diabetes Res Clin Pract; 2011 Oct; 94(1):133-9. PubMed ID: 21824673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
